Never miss an update from Eluemuno Blyden
Create your free account to connect with Eluemuno Blyden and thousands of other innovative organizations and professionals worldwide
We are offering our bioinformatics and egg-based protein expression technology for development of next generation diagnostics, therapeutics and vaccines.
Create your next recombinant product using our efficient and inexpensive research & development services for recombinant vaccine, therapeutic, diagnostic or research products:
● Genomics/Bioinformatics
● Sequence and protein structure engineering
● Production
● Purification and product
stabilization
● Rapid scale-up to GMP manufacturing.
Desired business relationship
Technology selling
Joint ventures
New technology applications
Avril Biopharma is a future-of-medicine company developing biopharmaceutical products using:
-- Customized interventions for rare diseases and gene therapy (anti-cancer vaccines; enzyme therapy, AAV viral vectors);
-- Rapid development and production scale-up or scale-down for vaccines, therapeutics, biosimilars & diagnostics.
Our goal is to enable a future of rapid, safe and affordable personalized medicine for all.
COVID-19: In an effort to contribute our technology and know-how to the fight against COVID19, we are interested in working with companies developing recombinant protein countermeasures for diagnostics, therapeutics or vaccine products. Please contact Dr. Blyden at the address provided or on LinkedIn.
Create your free account to connect with Eluemuno Blyden and thousands of other innovative organizations and professionals worldwide
Send a request for information
to Eluemuno
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support